Search research articles
Contact Us
Filters
Showing results (61-70 of 103) with videos related to
Page
of 11
Sort By:
The Lancet. HIV
|
June 21, 2025
Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis
Gert van Zyl, Mateo Prochazka, Heather-Marie Ann Schmidt, et al.
Plos One
|
December 2, 2016
Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia
Nicholus Mutenda, Alexandra Bukowski, Anne-Marie Nitschke, et al.
The Lancet. HIV
|
October 2, 2015
Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis
Andrew N Phillips, Valentina Cambiano, Alec Miners, et al.
The Lancet. HIV
|
September 16, 2023
Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use
Lawrence Mbuagbaw, Cristian Garcia, Bluma Brenner, et al.
Plos One
|
March 20, 2013
Medication possession ratio associated with short-term virologic response in individuals initiating antiretroviral therapy in Namibia
Steven Y Hong, Logan Jerger, Anna Jonas, et al.
The Journal of Infectious Diseases
|
November 17, 2020
Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis
Silvia Bertagnolio, Lucas Hermans, Michael R Jordan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 8, 2015
Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia
Steven Y Hong, Anna Jonas, Michael DeKlerk, et al.
AIDS (London, England)
|
August 8, 2013
Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study
Brooke E Nichols, Kim C E Sigaloff, Cissy Kityo, et al.
AIDS (London, England)
|
June 1, 2019
Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age
Seth Chekata Inzaule, Michael R Jordan, Amandine Cournil, et al.
Plos One
|
February 2, 2017
High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea
Evelyn Lavu, Ellan Kave, Euodia Mosoro, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 103) with videos related to
Sort By:
Page
of 11
The Lancet. HIV
|
June 21, 2025
Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis
Gert van Zyl, Mateo Prochazka, Heather-Marie Ann Schmidt, et al.
Plos One
|
December 2, 2016
Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia
Nicholus Mutenda, Alexandra Bukowski, Anne-Marie Nitschke, et al.
The Lancet. HIV
|
October 2, 2015
Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis
Andrew N Phillips, Valentina Cambiano, Alec Miners, et al.
The Lancet. HIV
|
September 16, 2023
Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use
Lawrence Mbuagbaw, Cristian Garcia, Bluma Brenner, et al.
Plos One
|
March 20, 2013
Medication possession ratio associated with short-term virologic response in individuals initiating antiretroviral therapy in Namibia
Steven Y Hong, Logan Jerger, Anna Jonas, et al.
The Journal of Infectious Diseases
|
November 17, 2020
Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis
Silvia Bertagnolio, Lucas Hermans, Michael R Jordan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 8, 2015
Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia
Steven Y Hong, Anna Jonas, Michael DeKlerk, et al.
AIDS (London, England)
|
August 8, 2013
Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study
Brooke E Nichols, Kim C E Sigaloff, Cissy Kityo, et al.
AIDS (London, England)
|
June 1, 2019
Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age
Seth Chekata Inzaule, Michael R Jordan, Amandine Cournil, et al.
Plos One
|
February 2, 2017
High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea
Evelyn Lavu, Ellan Kave, Euodia Mosoro, et al.
Page
of 11